Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)

The article presents an assessment of the clinical, economic and clinical-economic components of the basic anti-asthmatic therapy regimens in children in hospital setting. The analysis involved mathematical and statistical modeling methods, such as beta distribution, gamma distribution, Monte-Carlo...

Full description

Saved in:
Bibliographic Details
Main Author: O. V. Zhukova
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2017-06-01
Series:Сеченовский вестник
Subjects:
Online Access:https://www.sechenovmedj.com/jour/article/view/23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244712581464064
author O. V. Zhukova
author_facet O. V. Zhukova
author_sort O. V. Zhukova
collection DOAJ
description The article presents an assessment of the clinical, economic and clinical-economic components of the basic anti-asthmatic therapy regimens in children in hospital setting. The analysis involved mathematical and statistical modeling methods, such as beta distribution, gamma distribution, Monte-Carlo simulation based on simulation of the distribution. The study material was the baseline therapy of bronchial asthma exacerbation in children in hospital setting. The study includes the pharmacotherapy data from 608 inpatient records in 2014-2015. The basic anti-asthmatic therapy in hospital setting in the analyzed period was: 1) inhalation glucocorticoid (as a monotherapy); 2) a combination of an inhalation glucocorticosteroid and a short-acting β2-agonist; 3) a combination of an inhalation glucocorticosteroid and a long-acting β2-agonist; 4) a combination of an inhalation glucocorticosteroid and a leukotriene receptor antagonist; 5) a combination of an inhalation glucocorticosteroid, a short acting β2-agonist and a leukotriene receptor antagonist; 6) a combination of a short acting β2-agonist and a leukotriene receptor antagonist. Βeta-distribution was used to calculate the clinical outcome probability, and gamma distribution was used to calculate the costs. The highest values of confidence-based clinical efficacy, calculated on the basis of beta distribution and demonstrating the probability of a positive clinical effect, are characteristic for the regimens that include a combination of an inhalation glucocorticosteroid and a leukotriene receptor antagonist, as well as an inhalation glucocorticosteroid regimen and a long-acting β2-agonist. Similarly, the average cost of treatment regimens were determined. It based on gamma distribution. The combination of the results of these two distributions for each treatment regimen on the graph allowed us to obtain a cloud of distributions that clearly illustrates the clinical and economic effectiveness of the therapy regimens analyzed when used in the population. The article presents the curves of beta distributions and a graphic representation of Monte-Carlo simulation results.
format Article
id doaj-art-8e78f538992c48ee953ca0b8ca396ca2
institution Kabale University
issn 2218-7332
2658-3348
language Russian
publishDate 2017-06-01
publisher Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
record_format Article
series Сеченовский вестник
spelling doaj-art-8e78f538992c48ee953ca0b8ca396ca22025-08-20T03:59:04ZrusFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Сеченовский вестник2218-73322658-33482017-06-0102677222Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)O. V. Zhukova0Nizhny Novgorod State Medical AcademyThe article presents an assessment of the clinical, economic and clinical-economic components of the basic anti-asthmatic therapy regimens in children in hospital setting. The analysis involved mathematical and statistical modeling methods, such as beta distribution, gamma distribution, Monte-Carlo simulation based on simulation of the distribution. The study material was the baseline therapy of bronchial asthma exacerbation in children in hospital setting. The study includes the pharmacotherapy data from 608 inpatient records in 2014-2015. The basic anti-asthmatic therapy in hospital setting in the analyzed period was: 1) inhalation glucocorticoid (as a monotherapy); 2) a combination of an inhalation glucocorticosteroid and a short-acting β2-agonist; 3) a combination of an inhalation glucocorticosteroid and a long-acting β2-agonist; 4) a combination of an inhalation glucocorticosteroid and a leukotriene receptor antagonist; 5) a combination of an inhalation glucocorticosteroid, a short acting β2-agonist and a leukotriene receptor antagonist; 6) a combination of a short acting β2-agonist and a leukotriene receptor antagonist. Βeta-distribution was used to calculate the clinical outcome probability, and gamma distribution was used to calculate the costs. The highest values of confidence-based clinical efficacy, calculated on the basis of beta distribution and demonstrating the probability of a positive clinical effect, are characteristic for the regimens that include a combination of an inhalation glucocorticosteroid and a leukotriene receptor antagonist, as well as an inhalation glucocorticosteroid regimen and a long-acting β2-agonist. Similarly, the average cost of treatment regimens were determined. It based on gamma distribution. The combination of the results of these two distributions for each treatment regimen on the graph allowed us to obtain a cloud of distributions that clearly illustrates the clinical and economic effectiveness of the therapy regimens analyzed when used in the population. The article presents the curves of beta distributions and a graphic representation of Monte-Carlo simulation results.https://www.sechenovmedj.com/jour/article/view/23bronchial asthmaanti-asthmatic therapyclinical efficacyclinical and economic componentsimulation modelingbeta distributionconfidential clinical efficacygamma distributionmonte-carlo modelingleukotriene receptor antagonists
spellingShingle O. V. Zhukova
Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
Сеченовский вестник
bronchial asthma
anti-asthmatic therapy
clinical efficacy
clinical and economic component
simulation modeling
beta distribution
confidential clinical efficacy
gamma distribution
monte-carlo modeling
leukotriene receptor antagonists
title Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
title_full Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
title_fullStr Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
title_full_unstemmed Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
title_short Simulation modeling: an illustrative method to estimate drug clinical and economic effectiveness (retrospective meta-analysis of anti-asthmatic therapy in children in a hospital setting)
title_sort simulation modeling an illustrative method to estimate drug clinical and economic effectiveness retrospective meta analysis of anti asthmatic therapy in children in a hospital setting
topic bronchial asthma
anti-asthmatic therapy
clinical efficacy
clinical and economic component
simulation modeling
beta distribution
confidential clinical efficacy
gamma distribution
monte-carlo modeling
leukotriene receptor antagonists
url https://www.sechenovmedj.com/jour/article/view/23
work_keys_str_mv AT ovzhukova simulationmodelinganillustrativemethodtoestimatedrugclinicalandeconomiceffectivenessretrospectivemetaanalysisofantiasthmatictherapyinchildreninahospitalsetting